NCT02965703 2026-03-18
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
46 trialsNCT02647099 2026-03-13
ALASCCA
Karolinska Institutet
Phase 3 Active not recruiting
NCT05036109 2026-02-10
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
M.D. Anderson Cancer Center
Phase NA Completed
NCT06728072 2026-02-09
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
Phase 2 Recruiting
NCT02394769 2025-12-04
ASPIRED
Massachusetts General Hospital
Phase NA Active not recruiting
NCT05411718 2025-11-13
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04379999 2025-08-07
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Fox Chase Cancer Center
Phase EARLY_PHASE1 Completed
NCT03326791 2025-07-31
ASAC
Oslo University Hospital
Phase 2/3 Active not recruiting
NCT02804815 2025-06-10
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
Phase 3 Active not recruiting
NCT02467582 2025-05-16
Adjuvant Aspirin Treatment for Colon Cancer Patients
Swiss Cancer Institute
Phase 3 Terminated
NCT00357682 2025-05-01
AspECT
University of Oxford
Phase 3 Completed
NCT05158374 2025-02-06
Molecular Effects of Aspirin & Metformin on Colonic Epithelium
University of Edinburgh
Phase NA Withdrawn
NCT04214990 2024-12-27
EASTERN
National Cancer Center, Korea
Phase 3 Recruiting
NCT04534218 2024-12-20
REPROGRAM-01
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT05462613 2024-12-20
REPROGRAM-02
Centre Hospitalier Universitaire de Besancon
Phase 2/3 Recruiting
NCT03464305 2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3 Active not recruiting
NCT02301286 2024-03-18
ASPIRIN
Leiden University Medical Center
Phase 3 Active not recruiting
NCT04245644 2024-03-12
CAOS
IRCCS San Raffaele
Active not recruiting
NCT00565708 2024-02-02
ASCOLT
National Cancer Centre, Singapore
Phase 3 Unknown
NCT05637567 2023-11-13
ASAP
German Cancer Research Center
Phase 2 Not yet recruiting
NCT00578721 2023-07-07
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
University of California, Irvine
Phase 2 Completed
NCT05402124 2022-06-02
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study
University of Calgary
Phase 2 Unknown
NCT04081831 2022-04-19
ENgAGE-HK
Bayer
Completed
NCT02326779 2021-04-27
Low-dose Aspirin Therapy for Esophageal Cancer
Zhejiang University
Phase 3 Withdrawn
NCT03904732 2021-02-01
PEACOCS
Bayer
Completed
NCT03170115 2020-12-17
ICAR
Instituto Nacional de Cancer, Brazil
Phase 2 Terminated
NCT03603366 2020-10-05
Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum
Bayer
Completed
NCT03579732 2020-09-29
ENgAGE-Taiwan
Bayer
Completed
NCT03743883 2020-06-01
ENgAGE-UK
Bayer
Completed
NCT00272324 2020-03-13
Aspirin/Folate Prevention of Large Bowel Polyps
Dartmouth-Hitchcock Medical Center
Phase 2/3 Completed
NCT01936233 2019-08-05
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Fudan University
Phase 3 Unknown
NCT02748304 2019-02-15
Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
Fudan University
Phase NA Terminated
NCT00468910 2017-05-31
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02497820 2016-08-25
CaPP3 Israel
Tel-Aviv Sourasky Medical Center
Phase 3 Not yet recruiting
NCT00002527 2016-07-04
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02607072 2015-11-18
APREMEC
The Fourth Affiliated Hospital of Anhui Medical University
Phase 3 Unknown
NCT02602938 2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2 Unknown
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT02125409 2014-05-05
Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action
Aragon Institute of Health Sciences
Phase 3 Unknown
NCT00033319 2013-09-17
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
National Cancer Institute (NCI)
Phase NA Unknown
NCT01786200 2013-02-07
Physiological Effects of Altering Cancer-related Inflammation
NHS Greater Glasgow and Clyde
Phase NA Unknown
NCT00062023 2012-07-30
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00224679 2012-06-05
APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT01549418 2012-03-09
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 4 Unknown
NCT00637988 2011-01-21
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca
Phase 4 Completed